, , , ,

Roche scores win in slowing aggressive type of breast cancer

An immunotherapy cocktail from Roche helped slow an aggressive type of breast cancer where new treatments have proven elusive, offering positive news for the Swiss drugmaker as it chases medicines produced by its rivals.
, , , ,

Roche’s Tecentriq boosts survival in triple-negative breast cancer

An immunotherapy cocktail from Roche helped slow a type of breast cancer where new treatments have proven elusive, data released on Saturday showed, offering positive news for the Swiss drugmaker as it chases medicines produced by its rivals.
, , , ,

Novartis drug cut death risk by 35 percent in gene mutation breast cancer

An experimental cancer drug that Novartis hopes will raise the profile of its oncology portfolio cut the risk of death or disease progression by more than a third in breast cancer patients with a hard-to-target gene mutation.
, , , ,

Sanofi drug Dupixent wins FDA approval to treat asthma

France's Sanofi SA said on Friday eczema drug Dupixent was approved by the U.S. Food and Drug Administration as an additional maintenance therapy in patients with two types of asthma.
, , , ,

New health insurer policy may mean you pay for your ER visit

(Reuters Health) - While symptoms like chest or belly pain might reasonably drive you to the emergency room with worries about a heart attack or appendicitis, your insurance company might decide not to pay if it turns out your fears were unfounded, a new study suggests.
, , , ,

Too many people missing out on health benefits of golf, some experts say

(Reuters Health) - Playing golf is associated with better strength and balance, a sharper mind, a lower risk of heart disease and a longer life, according to public health experts who say more people should take up the sport.
, , , ,

Hispanic heart disease deaths highest in mostly-Latino communities

(Reuters Health) - Hispanics in the U.S. have lower rates of death from heart disease overall than non-Hispanic whites, except in communities where Hispanics make up most of the population, a recent study finds.
, , , ,

U.S. official optimistic Congo Ebola outbreak can be controlled

The leading Ebola expert at the U.S. Centers for Disease Control and Prevention (CDC) said on Friday he believed an outbreak in Congo can be brought under control quickly and that the high rate of new cases is due largely to improved detection.
, , , ,

Elite athletes not at higher risk of birth complications

(Reuters Health) - Elite female athletes have no greater risk of childbirth complications than women who don't exercise, a small study suggests.
, , , ,

Shire’s drug for rare swelling disorder wins European panel green light

A European Medicines Agency (EMA) panel on Friday recommended approving a potential blockbuster drug from Shire Plc to treat patients aged 12 and older with a rare hereditary disease that causes swelling in different parts of the body.